Literature DB >> 19078542

Myasthenic crisis after resection of an isolated metastatic thymoma of the cervical spine.

N Selvaraj1, D A Chad, T W Smith, D H Weinberg, J P Weaver.   

Abstract

A 73-year-old man presented with cervical cord compression resulting from a metastatic spindle cell thymoma 10 years after undergoing thymectomy for thymoma-associated myasthenia gravis. After being virtually asymptomatic following thymectomy, his myasthenic symptoms returned 3 months after removal of the spinal metastasis, culminating in myasthenic crisis that required immunosuppression and plasma exchange This case shows that isolated, extrathoracic metastases without any mediastinal tumor may occur many years after apparent surgical cure of primary thymoma, and that myasthenia gravis may recur after surgical resection of a thymic metastasis.

Entities:  

Year:  1999        PMID: 19078542     DOI: 10.1097/00131402-199909000-00004

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  4 in total

1.  Metastatic thymoma presenting as spontaneous epidural lumbar haematoma.

Authors:  Ganeshwaran Shivapathasundram; Vanessa Sammons; Renata Bazina
Journal:  Eur Spine J       Date:  2015-05-27       Impact factor: 3.134

2.  Malignant thymoma with metastasis associated with paraneoplastic myasthenia gravis.

Authors:  Hourossadat Hashemi Jazi; David M Harmon; Tuan Tran; Claude Denham
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

Review 3.  Surgical management of spinal metastases of thymic carcinoma: A case report and literature review.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; William A Li; Radhika Rastogi; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 4.  Successful treatment of malignant thymoma with sacrum metastases: A case report and review of literature.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; William A Li; Radhika Rastogi; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.